Yuki Nishikawa

Title: Yuki Nishikawa: Innovator in Pharmaceutical Technology

Introduction

Yuki Nishikawa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Nishikawa continues to push the boundaries of pharmaceutical science.

Latest Patents

Nishikawa's latest patents include an orally disintegrating tablet coated with film and a sustained-release preparation containing pseudoephedrine. The orally disintegrating tablet is film-coated with a composition that includes hypromellose and hydroxypropyl cellulose, while notably excluding a plasticizer. His sustained-release preparation comprises pseudoephedrine or a pharmaceutically acceptable salt thereof, combined with a hardened oil or stearic acid. This preparation may contain these components in a mass ratio ranging from 100% to 500% relative to the pseudoephedrine content. Additionally, the formulation may feature a first part containing pseudoephedrine and a second part that may include an optional active ingredient.

Career Highlights

Nishikawa is currently employed at Sawai Pharmaceutical Co., Ltd., where he applies his expertise in drug formulation and development. His work has been instrumental in advancing the company's pharmaceutical offerings and enhancing patient care through innovative solutions.

Collaborations

Nishikawa collaborates with talented colleagues, including Hiroyuki Yamamoto and Michinori Oikawa. Their combined efforts contribute to the success of their projects and the advancement of pharmaceutical technology.

Conclusion

Yuki Nishikawa is a notable inventor whose work in pharmaceutical technology has led to significant advancements in drug formulations. His innovative patents reflect his commitment to improving healthcare solutions.